Generic placeholder image

Protein & Peptide Letters

Author(s): Lucas Miranda Kangussu*, Tatiane Cristine S. de Almeida, Thiago Ruiz R. Prestes, Marilda Luz de Andrade De Maria, Roberta da Silva Filha, Maria Aparecida Ribeiro Vieira, Ana Cristina Simões e Silva and Anderson José Ferreira*

DOI: 10.2174/0929866526666190405123422

DownloadDownload PDF Flyer Cite As
Beneficial Effects of the Angiotensin-Converting Enzyme 2 Activator Dize in Renovascular Hypertension

Page: [523 - 531] Pages: 9

  • * (Excluding Mailing and Handling)

Abstract

Background: Angiotensin Converting Enzyme (ACE) 2 is an important modulator of the Renin Angiotensin System (RAS) and the RAS plays a central role in renovascular hypertension. Very few studies investigated the role of components of the counterregulatory RAS axis (ACE2, Ang-(1-7) and Mas receptor) in renovascular hypertension and the results are controversial.

Objective: The aim of this study was to investigate the effects of Diminazene Aceturate (DIZE) administration on renal function and renal inflammation parameters in 2K1C hypertensive rats.

Methods: Male Wistar rats were divided into three experimental groups: sham-operated animals, 2K1C+saline and 2K1C+DIZE orally (1 mg/kg/day). At the end of the 30 days of treatment, renal function was analyzed and kidneys from all the groups were collected and processed separately for measurement of N-acetyl-beta-D-glucosaminidase (NAG) and Myeloperoxidase (MPO) activities, cytokines, chemokines and nitric oxide levels.

Results: Oral DIZE administration for 4 weeks in hypertensive rats attenuated renal dysfunction and reduced the levels of MPO and NAG, cytokines and chemokines (IL1β, IL-6, TNF-α and MCP-1) and increased urinary nitrate/nitrite levels in 2K1C hypertensive rats.

Conclusion: Our findings showed that ACE2 activation may effectively improve renal alterations and inflammation induced by renovascular hypertension.

Keywords: ACE2 activation, diminazene aceturate, angiotensin-(1-7), renoprotection, renovascular hypertension, renin angiotensin system.

Graphical Abstract

[1]
Santos, R.A. Ferreira, A.J.; Verano-Braga, T.; Bader M. Angiotensin-converting enzyme 2, angiotensin-(1-7) and Mas: New players of the renin-angiotensin system. J. Endocrinol., 2013, 216, 1-17. [http://dx.doi.org/10.1530/JOE-12-0341].
[2]
Pickering, T.G. Renovascular hypertension: etiology and pathophysiology. Semin. Nucl. Med., 1989, 19(2), 79-88. [http://dx.doi.org/10.1016/S0001-2998(89)80003-0]. [PMID: 2652313].
[3]
Hackenthal, E.; Paul, M.; Ganten, D.; Taugner, R. Morphology, physiology, and molecular biology of renin secretion. Physiol. Rev., 1990, 70(4), 1067-1116. [http://dx.doi.org/10.1152/physrev.1990.70.4.1067]. [PMID: 2217555].
[4]
Deschepper, C.F. Angiotensinogen: Hormonal regulation and relative importance in the generation of angiotensin II. Kidney Int., 1994, 46(6), 1561-1563. [http://dx.doi.org/10.1038/ki.1994.446]. [PMID: 7700006].
[5]
Atlas, S.A. The renin-angiotensin aldosterone system: Pathophysiological role and pharmacologic inhibition. J. Manag. Care Pharm., 2007, 13(8)(Suppl. B), 9-20. [http://dx.doi.org/10.18553/jmcp.2007.13.s8-b.9]. [PMID: 17970613].
[6]
Kaschina, E.; Unger, T. Angiotensin AT1/AT2 receptors: Regulation, signalling and function. Blood Press., 2003, 12(2), 70-88. [http://dx.doi.org/10.1080/08037050310001057]. [PMID: 12797627].
[7]
Crowley, S.D.; Gurley, S.B.; Herrera, M.J.; Ruiz, P.; Griffiths, R.; Kumar, A.P.; Kim, H.S.; Smithies, O.; Le, T.H.; Coffman, T.M. Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney. Proc. Natl. Acad. Sci. USA, 2006, 103(47), 17985-17990. [http://dx.doi.org/10.1073/pnas.0605545103]. [PMID: 17090678].
[8]
Bivol, L.M.; Berge, R.K.; Iversen, B.M. Tetradecylthioacetic acid prevents the inflammatory response in two-kidney, one-clip hypertension. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2008, 294(2), R438-R447. [http://dx.doi.org/10.1152/ajpregu.00590.2007]. [PMID: 18032469].
[9]
Agarwal, R.; Campbell, R.C.; Warnock, D.G. Oxidative stress in hypertension and chronic kidney disease: Role of angiotensin II. Semin. Nephrol., 2004, 24(2), 101-114. [http://dx.doi.org/10.1016/j.semnephrol.2003.11.008]. [PMID: 15017522].
[10]
Minuz, P.; Patrignani, P.; Gaino, S.; Degan, M.; Menapace, L.; Tommasoli, R.; Seta, F.; Capone, M.L.; Tacconelli, S.; Palatresi, S.; Bencini, C.; Del Vecchio, C.; Mansueto, G.; Arosio, E.; Santonastaso, C.L.; Lechi, A.; Morganti, A.; Patrono, C. Increased oxidative stress and platelet activation in patients with hypertension and renovascular disease. Circulation, 2002, 106(22), 2800-2805. [http://dx.doi.org/10.1161/01.CIR.0000039528.49161.E9]. [PMID: 12451006].
[11]
Montezano, A.C.; Touyz, R.M. Reactive oxygen species, vascular Noxs, and hypertension: Focus on translational and clinical research. Antioxid. Redox Signal., 2014, 20(1), 164-182. [http://dx.doi.org/10.1089/ars.2013.5302]. [PMID: 23600794].
[12]
Navar, L.G.; Zou, L.; Von Thun, A.; Tarng Wang, C.; Imig, J.D.; Mitchell, K.D. Unraveling the mystery of Goldblatt hypertension. News Physiol. Sci., 1998, 13, 170-176. [PMID: 11390784].
[13]
Tipnis, S.R.; Hooper, N.M.; Hyde, R.; Karran, E.; Christie, G.; Turner, A.J. A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J. Biol. Chem., 2000, 275(43), 33238-33243. [http://dx.doi.org/10.1074/jbc.M002615200]. [PMID: 10924499].
[14]
Donoghue, M.; Hsieh, F.; Baronas, E.; Godbout, K.; Gosselin, M.; Stagliano, N.; Donovan, M.; Woolf, B.; Robison, K.; Jeyaseelan, R.; Breitbart, R.E.; Acton, S. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ. Res., 2000, 87(5), E1-E9. [http://dx.doi.org/10.1161/01.RES.87.5.e1]. [PMID: 10969042].
[15]
Santos, R.A.; Simoes e Silva, A.C.; Maric, C.; Silva, D.M.; Machado, R.P.; de Buhr, I.; Heringer-Walther, S.; Pinheiro, S.V.; Lopes, M.T.; Bader, M.; Mendes, E.P.; Lemos, V.S.; Campagnole-Santos, M.J.; Schultheiss, H.P.; Speth, R.; Walther, T. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc. Natl. Acad. Sci. USA, 2003, 100(14), 8258-8263. [http://dx.doi.org/10.1073/pnas.1432869100]. [PMID: 12829792].
[16]
Bürgelová, M.; Vanourková, Z.; Thumová, M.; Dvorák, P.; Opocenský, M.; Kramer, H.J.; Zelízko, M.; Malý, J.; Bader, M.; Cervenka, L. Impairment of the angiotensin-converting enzyme 2-angiotensin-(1-7)-Mas axis contributes to the acceleration of two-kidney, one-clip Goldblatt hypertension. J. Hypertens., 2009, 27(10), 1988-2000. [http://dx.doi.org/10.1097/HJH.0b013e32832f0d06]. [PMID: 19593210].
[17]
Shah, A.; Oh, Y.B.; Lee, S.H.; Lim, J.M.; Kim, S.H. Angiotensin-(1-7) attenuates hypertension in exercise-trained renal hypertensive rats. Am. J. Physiol. Heart Circ. Physiol., 2012, 302(11), H2372-H2380. [http://dx.doi.org/10.1152/ajpheart.00846.2011]. [PMID: 22467306].
[18]
Rakušan, D.; Bürgelová, M.; Vaněčková, I.; Vaňourková, Z.; Husková, Z.; Skaroupková, P.; Mrázová, I.; Opočenský, M.; Kramer, H.J.; Netuka, I.; Malý, J.; Alenina, N.; Bader, M.; Santos, R.A.; Cervenka, L. Knockout of angiotensin 1-7 receptor Mas worsens the course of two-kidney, one-clip Goldblatt hypertension: Roles of nitric oxide deficiency and enhanced vascular responsiveness to angiotensin II. Kidney Blood Press. Res., 2010, 33(6), 476-488. [http://dx.doi.org/10.1159/000320689]. [PMID: 21071955].
[19]
Qi, Y.; Zhang, J.; Cole-Jeffrey, C.T.; Shenoy, V.; Espejo, A.; Hanna, M.; Song, C.; Pepine, C.J.; Katovich, M.J.; Raizada, M.K. Diminazene aceturate enhances angiotensin-converting enzyme 2 activity and attenuates ischemia-induced cardiac pathophysiology. Hypertension, 2013, 62(4), 746-752. [http://dx.doi.org/10.1161/HYPERTENSIONAHA.113.01337]. [PMID: 23959549].
[20]
De Maria, M.L.; Araújo, L.D.; Fraga-Silva, R.A.; Pereira, L.A.; Ribeiro, H.J.; Menezes, G.B.; Shenoy, V.; Raizada, M.K.; Ferreira, A.J. Anti-hypertensive effects of diminazene aceturate: An angiotensin-converting enzyme 2 activator in rats. Protein Pept. Lett., 2016, 23(1), 9-16. [http://dx.doi.org/10.2174/0929866522666151013130550]. [PMID: 26458404].
[21]
Velkoska, E.; Patel, S.K.; Griggs, K.; Pickering, R.J.; Tikellis, C.; Burrell, L.M. Short-term treatment with diminazene aceturate ameliorates the reduction in kidney ACE2 activity in rats with subtotal nephrectomy. PLoS One, 2015, 10(3)e0118758 [http://dx.doi.org/10.1371/journal.pone.0118758]. [PMID: 25786223].
[22]
Mecca, A.P.; Regenhardt, R.W.; O’Connor, T.E.; Joseph, J.P.; Raizada, M.K.; Katovich, M.J.; Sumners, C. Cerebroprotection by angiotensin-(1-7) in endothelin-1-induced ischaemic stroke. Exp. Physiol., 2011, 96(10), 1084-1096. [http://dx.doi.org/10.1113/expphysiol.2011.058578]. [PMID: 21685445].
[23]
Qiu, Y.; Shil, P.K.; Zhu, P.; Yang, H.; Verma, A.; Lei, B.; Li, Q. Angiotensin-converting enzyme 2 (ACE2) activator diminazene aceturate ameliorates endotoxin-induced uveitis in mice. Invest. Ophthalmol. Vis. Sci., 2014, 55(6), 3809-3818. [http://dx.doi.org/10.1167/iovs.14-13883]. [PMID: 24854854].
[24]
Goldblatt, H.; Lynch, J.; Hanzal, R.F.; Summerville, W.W. Studies on experimental hypertension: The production of persistent elevation of systolic blood pressure by means of renal ischemia. J. Exp. Med., 1934, 59(3), 347-379. [http://dx.doi.org/10.1084/jem.59.3.347]. [PMID: 19870251].
[25]
Cervenka, L.; Wang, C.T.; Mitchell, K.D.; Navar, L.G. Proximal tubular angiotensin II levels and renal functional responses to AT1 receptor blockade in nonclipped kidneys of Goldblatt hypertensive rats. Hypertension, 1999, 33(1), 102-107. [http://dx.doi.org/10.1161/01.HYP.33.1.102]. [PMID: 9931089].
[26]
Allred, A.J.; Diz, D.I.; Ferrario, C.M.; Chappell, M.C. Pathways for angiotensin-(1-7) metabolism in pulmonary and renal tissues. Am. J. Physiol. Renal Physiol., 2000, 279(5), F841-F850. [http://dx.doi.org/10.1152/ajprenal.2000.279.5.F841]. [PMID: 11053044].
[27]
Navar, L.G.; Nishiyama, A. Why are angiotensin concentrations so high in the kidney? Curr. Opin. Nephrol. Hypertens., 2004, 13(1), 107-115. [http://dx.doi.org/10.1097/00041552-200401000-00015]. [PMID: 15090867].
[28]
Jaimes, E.A.; Tian, R.X.; Pearse, D.; Raij, L. Up-regulation of glomerular COX-2 by angiotensin II: Role of reactive oxygen species. Kidney Int., 2005, 68(5), 2143-2153. [http://dx.doi.org/10.1111/j.1523-1755.2005.00670.x]. [PMID: 16221213].
[29]
Ren, Y.; Garvin, J.L.; Carretero, O.A. Vasodilator action of angiotensin-(1-7) on isolated rabbit afferent arterioles. Hypertension, 2002, 39(3), 799-802. [http://dx.doi.org/10.1161/hy0302.104673]. [PMID: 11897767].
[30]
Sampaio, W.O.; Nascimento, A.A.; Santos, R.A. Systemic and regional hemodynamic effects of angiotensin-(1-7) in rats. Am. J. Physiol. Heart Circ. Physiol., 2003, 284(6), H1985-H1994. [http://dx.doi.org/10.1152/ajpheart.01145.2002]. [PMID: 12573992].
[31]
Stegbauer, J.; Oberhauser, V.; Vonend, O.; Rump, L.C. Angiotensin-(1-7) modulates vascular resistance and sympathetic neurotransmission in kidneys of spontaneously hypertensive rats. Cardiovasc. Res., 2004, 61(2), 352-359. [http://dx.doi.org/10.1016/j.cardiores.2003.11.017]. [PMID: 14736552].
[32]
Pinheiro, S.V.B.; Ferreira, A.J.; Kitten, G.T.; da Silveira, K.D.; da Silva, D.A.; Santos, S.H.S.; Gava, E.; Castro, C.H.; Magalhães, J.A.; da Mota, R.K.; Botelho-Santos, G.A.; Bader, M.; Alenina, N.; Santos, R.A.S.; Simoes, E.; Silva, A.C. Genetic deletion of the angiotensin-(1-7) receptor Mas leads to glomerular hyperfiltration and microalbuminuria. Kidney Int., 2009, 75(11), 1184-1193. [http://dx.doi.org/10.1038/ki.2009.61]. [PMID: 19262461].
[33]
Silveira, K.D.; Barroso, L.C.; Vieira, A.T.; Cisalpino, D.; Lima, C.X.; Bader, M.; Arantes, R.M.; Dos Santos, R.A.; Simões-E-Silva, A.C.; Teixeira, M.M. Beneficial effects of the activation of the angiotensin-(1-7) MAS receptor in a murine model of adriamycin-induced nephropathy. PLoS One, 2013, 8(6)e66082 [http://dx.doi.org/10.1371/journal.pone.0066082]. [PMID: 23762470].
[34]
Barroso, L.C.; Silveira, K.D.; Lima, C.X.; Borges, V.; Bader, M.; Rachid, M.; Santos, R.A.; Souza, D.G.; Simões, E. Silva, A.C.; Teixeira, M.M. Renoprotective effects of AVE0991, a nonpeptide mass receptor agonist, in experimental acute renal injury. Int. J. Hypertens., 2012, 2012808726 [http://dx.doi.org/10.1155/2012/808726]. [PMID: 22319645].
[35]
Li, Y.; Wu, J.; He, Q.; Shou, Z.; Zhang, P.; Pen, W.; Zhu, Y.; Chen, J. Angiotensin (1-7) prevent heart dysfunction and left ventricular remodeling caused by renal dysfunction in 5/6 nephrectomy mice. Hypertens. Res., 2009, 32(5), 369-374. [http://dx.doi.org/10.1038/hr.2009.25]. [PMID: 19325560].
[36]
Dilauro, M.; Zimpelmann, J.; Robertson, S.J.; Genest, D.; Burns, K.D. Effect of ACE2 and angiotensin-(1-7) in a mouse model of early chronic kidney disease. Am. J. Physiol. Renal Physiol., 2010, 298(6), F1523-F1532. [http://dx.doi.org/10.1152/ajprenal.00426.2009]. [PMID: 20357030].
[37]
Oudit, G.Y.; Herzenberg, A.M.; Kassiri, Z.; Wong, D.; Reich, H.; Khokha, R.; Crackower, M.A.; Backx, P.H.; Penninger, J.M.; Scholey, J.W. Loss of angiotensin-converting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosis. Am. J. Pathol., 2006, 168(6), 1808-1820. [http://dx.doi.org/10.2353/ajpath.2006.051091]. [PMID: 16723697].
[38]
Soler, M.J.; Wysocki, J.; Ye, M.; Lloveras, J.; Kanwar, Y.; Batlle, D. ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice. Kidney Int., 2007, 72(5), 614-623. [http://dx.doi.org/10.1038/sj.ki.5002373]. [PMID: 17579661].
[39]
Wong, D.W.; Oudit, G.Y.; Reich, H.; Kassiri, Z.; Zhou, J.; Liu, Q.C.; Backx, P.H.; Penninger, J.M.; Herzenberg, A.M.; Scholey, J.W. Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury. Am. J. Pathol., 2007, 171(2), 438-451. [http://dx.doi.org/10.2353/ajpath.2007.060977]. [PMID: 17600118].
[40]
Ye, M.; Wysocki, J.; William, J.; Soler, M.J.; Cokic, I.; Batlle, D. Glomerular localization and expression of Angiotensin-converting enzyme 2 and Angiotensin-converting enzyme: implications for albuminuria in diabetes. J. Am. Soc. Nephrol., 2006, 17(11), 3067-3075. [http://dx.doi.org/10.1681/ASN.2006050423]. [PMID: 17021266].
[41]
da Silveira, K.D.; Pompermayer Bosco, K.S.; Diniz, L.R.; Carmona, A.K.; Cassali, G.D.; Bruna-Romero, O.; de Sousa, L.P.; Teixeira, M.M.; Santos, R.A.; Simões e Silva, A.C.; Ribeiro Vieira, M.A. ACE2-angiotensin-(1-7)-Mas axis in renal ischaemia/reperfusion injury in rats. Clin. Sci. (Lond.), 2010, 119(9), 385-394. [http://dx.doi.org/10.1042/CS20090554]. [PMID: 20528771].
[42]
Lara, L.S.; De Carvalho, T.; Leão-Ferreira, L.R.; Lopes, A.G.; Caruso-Neves, C. Modulation of the (Na(+)+K+)ATPase activity by Angiotensin-(1-7) in MDCK cells. Regul. Pept., 2005, 129(1-3), 221-226. [http://dx.doi.org/10.1016/j.regpep.2005.02.014]. [PMID: 15927719].
[43]
DelliPizzi, A.M.; Hilchey, S.D.; Bell-Quilley, C.P. Natriuretic action of angiotensin (1-7). Br. J. Pharmacol., 1994, 111(1), 1-3. [http://dx.doi.org/10.1111/j.1476-5381.1994.tb14014.x]. [PMID: 8012686].
[44]
Vallon, V.; Richter, K.; Heyne, N.; Osswald, H. Effect of intratubular application of angiotensin 1-7 on nephron function. Kidney Blood Press. Res., 1997, 20(4), 233-239. [http://dx.doi.org/10.1159/000174151]. [PMID: 9398028].
[45]
Bürgelová, M.; Kramer, H.J.; Teplan, V.; Velicková, G.; Vítko, S.; Heller, J.; Malý, J.; Cervenka, L. Intrarenal infusion of angiotensin-(1-7) modulates renal functional responses to exogenous angiotensin II in the rat. Kidney Blood Press. Res., 2002, 25(4), 202-210. [http://dx.doi.org/10.1159/000066340]. [PMID: 12424421].
[46]
Santos, R.A.; Simões e Silva, A.C.; Magaldi, A.J.; Khosla, M.C.; Cesar, K.R.; Passaglio, K.T.; Baracho, N.C. Evidence for a physiological role of angiotensin-(1-7) in the control of hydroelectrolyte balance. Hypertension, 1996, 27(4), 875-884. [http://dx.doi.org/10.1161/01.HYP.27.4.875]. [PMID: 8613263].
[47]
Simões e Silva, A.C.; Bello, A.P.; Baracho, N.C.; Khosla, M.C.; Santos, R.A. Diuresis and natriuresis produced by long term administration of a selective Angiotensin-(1-7) antagonist in normotensive and hypertensive rats. Regul. Pept., 1998, 74(2-3), 177-184. [http://dx.doi.org/10.1016/S0167-0115(98)00038-X]. [PMID: 9712179].
[48]
Magaldi, A.J.; Cesar, K.R.; de Araújo, M.; Simões e Silva, A.C.; Santos, R.A. Angiotensin-(1-7) stimulates water transport in rat inner medullary collecting duct: Evidence for involvement of vasopressin V2 receptors. Pflugers Arch., 2003, 447(2), 223-230. [http://dx.doi.org/10.1007/s00424-003-1173-1]. [PMID: 14534790].
[49]
Pinheiro, S.V.; Simões e Silva, A.C.; Sampaio, W.O.; de Paula, R.D.; Mendes, E.P.; Bontempo, E.D.; Pesquero, J.B.; Walther, T.; Alenina, N.; Bader, M.; Bleich, M.; Santos, R.A. Nonpeptide AVE 0991 is an angiotensin-(1-7) receptor Mas agonist in the mouse kidney. Hypertension, 2004, 44(4), 490-496. [http://dx.doi.org/10.1161/01.HYP.0000141438.64887.42]. [PMID: 15326087].
[50]
Baracho, N.C.; Simões-e-Silva, A.C.; Khosla, M.C.; Santos, R.A. Effect of selective angiotensin antagonists on the antidiuresis produced by angiotensin-(1-7) in water-loaded rats. Braz. J. Med. Biol. Res., 1998, 31(9), 1221-1227. [http://dx.doi.org/10.1590/S0100-879X1998000900016]. [PMID: 9876290].
[51]
Vianna, H.R.; Soares, C.M.; Tavares, M.S.; Teixeira, M.M.; Silva, A.C. Inflammation in chronic kidney disease: the role of cytokines. J. Bras. Nefrol., 2011, 33(3), 351-364. [http://dx.doi.org/10.1590/S0101-28002011000300012]. [PMID: 22042353].
[52]
Matavelli, L.C.; Huang, J.; Siragy, H.M. Angiotensin AT2 receptor stimulation inhibits early renal inflammation in renovascular hypertension. Hypertension, 2011, 57(2), 308-313. [http://dx.doi.org/10.1161/HYPERTENSIONAHA.110.164202]. [PMID: 21189405].
[53]
Cheng, J.; Zhou, W.; Warner, G.M.; Knudsen, B.E.; Garovic, V.D.; Gray, C.E.; Lerman, L.O.; Platt, J.L.; Romero, J.C.; Textor, S.C.; Nath, K.A.; Grande, J.P. Temporal analysis of signaling pathways activated in a murine model of two-kidney, one-clip hypertension. Am. J. Physiol. Renal Physiol., 2009, 297(4), F1055-F1068. [http://dx.doi.org/10.1152/ajprenal.90439.2008]. [PMID: 19625373].
[54]
Zheng, C.; Lei, C.; Chen, Z.; Zheng, S.; Yang, H.; Qiu, Y.; Lei, B. Topical administration of diminazene aceturate decreases inflammation in endotoxin-induced uveitis. Mol. Vis., 2015, 21, 403-411. [PMID: 25883526].
[55]
Tao, L.; Qiu, Y.; Fu, X.; Lin, R.; Lei, C.; Wang, J.; Lei, B. Angiotensin-converting enzyme 2 activator diminazene aceturate prevents lipopolysaccharide-induced inflammation by inhibiting MAPK and NF-κB pathways in human retinal pigment epithelium. J. Neuroinflammation, 2016, 13, 35. [http://dx.doi.org/10.1186/s12974-016-0489-7]. [PMID: 26862037].
[56]
Rodrigues Prestes, T.R.; Rocha, N.P.; Miranda, A.S.; Teixeira, A.L. Simoes-E-Silva, A.C. Simoes-E-Silva, A.C. The anti-inflammatory potential of ACE2/Angiotensin-(1-7)/Mas receptor axis: Evidence from basic and clinical research. Curr. Drug Targets, 2017, 18(11), 1301-1313. [http://dx.doi.org/10.2174/1389450117666160727142401]. [PMID: 27469342].